2023-2024年美国因COVID-19、流感和呼吸道合胞病毒而住院的年度人数

IF 6.6 2区医学 Q1 IMMUNOLOGY Emerging Infectious Diseases Pub Date : 2025-02-21 DOI:10.3201/eid3103.240594

Kaiming Bi, Shraddha Ramdas Bandekar, Anass Bouchnita, Spencer J. Fox, Lauren Ancel Meyers

{"title":"2023-2024年美国因COVID-19、流感和呼吸道合胞病毒而住院的年度人数","authors":"Kaiming Bi, Shraddha Ramdas Bandekar, Anass Bouchnita, Spencer J. Fox, Lauren Ancel Meyers","doi":"10.3201/eid3103.240594","DOIUrl":null,"url":null,"abstract":"<p>Projections for the US 2023–24 respiratory virus season indicated a 31% decrease to a 55% increase in hospitalizations for respiratory syncytial virus, influenza, and COVID-19 compared with 2022–23, depending on circulating variants and vaccination uptake. The projections captured the tripledemic peak but missed the multiwave seasonality of COVID-19.</p>","PeriodicalId":11595,"journal":{"name":"Emerging Infectious Diseases","volume":"25 1","pages":""},"PeriodicalIF":6.6000,"publicationDate":"2025-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Annual Hospitalizations for COVID-19, Influenza, and Respiratory Syncytial Virus, United States, 2023–2024\",\"authors\":\"Kaiming Bi, Shraddha Ramdas Bandekar, Anass Bouchnita, Spencer J. Fox, Lauren Ancel Meyers\",\"doi\":\"10.3201/eid3103.240594\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Projections for the US 2023–24 respiratory virus season indicated a 31% decrease to a 55% increase in hospitalizations for respiratory syncytial virus, influenza, and COVID-19 compared with 2022–23, depending on circulating variants and vaccination uptake. The projections captured the tripledemic peak but missed the multiwave seasonality of COVID-19.</p>\",\"PeriodicalId\":11595,\"journal\":{\"name\":\"Emerging Infectious Diseases\",\"volume\":\"25 1\",\"pages\":\"\"},\"PeriodicalIF\":6.6000,\"publicationDate\":\"2025-02-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Emerging Infectious Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3201/eid3103.240594\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Emerging Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3201/eid3103.240594","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

对美国2023-24呼吸道病毒季节的预测显示，与2022-23年相比，呼吸道合胞病毒、流感和COVID-19的住院率将下降31%至55%，具体取决于流行变体和疫苗接种率。这些预测捕捉到了三次疫情的高峰，但没有考虑到COVID-19的多波季节性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Annual Hospitalizations for COVID-19, Influenza, and Respiratory Syncytial Virus, United States, 2023–2024

Projections for the US 2023–24 respiratory virus season indicated a 31% decrease to a 55% increase in hospitalizations for respiratory syncytial virus, influenza, and COVID-19 compared with 2022–23, depending on circulating variants and vaccination uptake. The projections captured the tripledemic peak but missed the multiwave seasonality of COVID-19.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Emerging Infectious Diseases 医学-传染病学

CiteScore

17.30

自引率

1.70%

发文量

505

审稿时长

1 months

期刊介绍： Emerging Infectious Diseases is a monthly open access journal published by the Centers for Disease Control and Prevention. The primary goal of this peer-reviewed journal is to advance the global recognition of both new and reemerging infectious diseases, while also enhancing our understanding of the underlying factors that contribute to disease emergence, prevention, and elimination. Targeted towards professionals in the field of infectious diseases and related sciences, the journal encourages diverse contributions from experts in academic research, industry, clinical practice, public health, as well as specialists in economics, social sciences, and other relevant disciplines. By fostering a collaborative approach, Emerging Infectious Diseases aims to facilitate interdisciplinary dialogue and address the multifaceted challenges posed by infectious diseases.